Global Retinal Vein Occlusion Treatment Market Size & Outlook
Global retinal vein occlusion treatment market, 2018-2030 (US$M)
Related Markets
Global retinal vein occlusion treatment market highlights
- The global retinal vein occlusion treatment market generated a revenue of USD 2,478.1 million in 2022 and is expected to reach USD 4,182.5 million by 2030.
- The market is expected to grow at a CAGR (2023 - 2030) of 6.8% by 2030.
- In terms of segment, central retinal vein occlusion (crvo) accounted for a revenue of USD 1,690.2 million in 2022.
- Branch Retinal Vein Occlusion (BRVO) is the most lucrative disease type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2022.
- Country-wise, Norway is expected to register the highest CAGR from 2023 to 2030.
Global data book summary
| Market revenue in 2022 | USD 2,478.1 million |
| Market revenue in 2030 | USD 4,182.5 million |
| Growth rate | 6.8% (CAGR from 2022 to 2030) |
| Largest segment | Central retinal vein occlusion (crvo) |
| Fastest growing segment | Branch Retinal Vein Occlusion (BRVO) |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Central Retinal Vein Occlusion (CRVO), Branch Retinal Vein Occlusion (BRVO) |
Other key industry trends
- In terms of revenue, the North America accounted for 41.7% of the global retinal vein occlusion treatment market in 2022.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Norway is the fastest growing regional market and is projected to reach USD 9.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Retinal Vein Occlusion Treatment Market Scope
Retinal Vein Occlusion Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Chugai Pharmaceutical Co Ltd | View profile | 7604 | 1-1 Nihonbashi-Muromachi 2-Chome, Nihonbashi Mitsui Tower (Reception15F), Chuo-ku, Tokyo, Japan, 103-8324 | http://www.chugai-pharm.co.jp |
| Kodiak Sciences Inc | View profile | 107 | 1200 Page Mill Road, Palo Alto, CA, United States, 94304 | https://www.kodiak.com |
| Outlook Therapeutics Inc | View profile | 24 | 485 Route 1 South Building F, Suite 320, Iselin, NJ, United States, 08852 | https://www.outlooktherapeutics.com |
| CalciMedica Inc Ordinary Shares | View profile | 13 | 505 Coast Boulevard South, Suite 307, La Jolla, CA, United States, 92037 | https://www.graybug.vision |
| Taiwan Liposome | View profile | 101-250 | Taipei, T'ai-pei, Taiwan, Asia | http://www.tlcbio.com |
| Regeneron Pharmaceuticals Inc | View profile | 13450 | 777 Old Saw Mill River Road, Tarrytown, NY, United States, 10591-6707 | https://www.regeneron.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Alcon Inc | View profile | 25315 | Chemin de Blandonnet 8, Royce Bedward, Vernier, Geneva, Switzerland, 1214 | https://www.alcon.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
Global retinal vein occlusion treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to retinal vein occlusion treatment market will help companies and investors design strategic landscapes.
Central retinal vein occlusion (crvo) was the largest segment with a revenue share of 68.21% in 2022. Horizon Databook has segmented the Global retinal vein occlusion treatment market based on central retinal vein occlusion (crvo), branch retinal vein occlusion (brvo) covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Retinal Vein Occlusion Treatment Disease Type Outlook (Revenue, USD Million, 2018-2030)
- Central Retinal Vein Occlusion (CRVO)
- Branch Retinal Vein Occlusion (BRVO)
- Global Retinal Vein Occlusion Treatment Treatment Outlook (Revenue, USD Million, 2018-2030)
- Anti-vascular Endothelial Growth Factor (Anti-VEGF)
- Others
- Corticosteroid Drugs
- Global Retinal Vein Occlusion Treatment End-user Outlook (Revenue, USD Million, 2018-2030)
- Hospital & Clinics
- Retail Pharmacy
- Others
Reasons to subscribe to Global retinal vein occlusion treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global retinal vein occlusion treatment market databook
-
Our clientele includes a mix of retinal vein occlusion treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global retinal vein occlusion treatment market , including forecasts for subscribers. This global databook contains high-level insights into Global retinal vein occlusion treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global retinal vein occlusion treatment market report size, by regions, 2018-2030 (US$M)
Top 10 countries: Retinal vein occlusion treatment market report size, 2022 (US$M)
Global retinal vein occlusion treatment market report share, by treatment, 2022 & 2030 (%, US$M)
Retinal vein occlusion treatment market: Opportunity assessment by country
Global retinal vein occlusion treatment market, by region, 2022 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
